Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transfection of a Molecular Clone of Naegleria gruberi rDNA into N. gruberi Trophozoites.

Journal of visualized experiments : JoVE·2024
Same author

Complete sequence of the closed circular extrachromosomal element of <i>Naegleria pringsheimi</i> De Jonckheere (strain Singh).

Microbiology resource announcements·2024
Same author

Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity.

Nutrients·2023
Same author

Complete sequence of the closed circular extrachromosomal element (CERE) of <i>Naegleria australiensis</i> De Jonckheere (strain PP 397).

Microbiology resource announcements·2023
Same author

Complete Sequence of the Closed Circular Extrachromosomal Element of Naegleria jadini Willaert and Ray (Strain ITMAP400).

Microbiology resource announcements·2023
Same author

Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses.

Nature communications·2023

Related Experiment Video

Updated: May 27, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Enteroviruses and type 1 diabetes.

Steven Tracy1, Kristen M Drescher, Nora M Chapman

  • 1Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA. stracy@unmc.edu

Diabetes/Metabolism Research and Reviews
|November 10, 2011
PubMed
Summary
This summary is machine-generated.

Enteroviruses are linked to type 1 diabetes, but this study found no viral RNA in pancreas samples. Further research with pancreas biopsies is needed to confirm the role of enteroviruses in type 1 diabetes.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Experiment Videos

Last Updated: May 27, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Area of Science:

  • Virology
  • Immunology
  • Endocrinology

Background:

  • Human enteroviruses, transmitted via the fecal-oral route, are associated with type 1 diabetes onset.
  • Increased hygiene may reduce early-life enterovirus exposure, potentially increasing later-life infections and diabetes risk.
  • This hypothesis is supported by observations linking hygiene, polio epidemics, and diabetes rates.

Purpose of the Study:

  • To investigate the presence of enteroviral RNA in pancreatic tissue samples from individuals with type 1 diabetes.
  • To explore the potential role of enteroviruses in the etiology of type 1 diabetes.

Main Methods:

  • Samples from the Network for Pancreatic Organ Donors with Diabetes were analyzed.
  • Reverse transcription polymerase chain reaction (RT-PCR) was used to detect enteroviral RNA.

Main Results:

  • Enteroviral RNA was not detected in the examined pancreatic samples.

Conclusions:

  • While a definitive link between enteroviruses and type 1 diabetes remains difficult to refute, current evidence is inconclusive.
  • Availability of pancreas biopsy tissue at the time of diagnosis is crucial for definitively linking enteroviruses to type 1 diabetes.
  • Further research is required to establish the specific role of enteroviruses in the etiology of human type 1 diabetes.